Claudia Adrien

Senior Correspondent

"Claudia Adrien is a journalist who writes about personalized nutrition, longevity, the microbiome, supplements and how the science, business and legal aspects of these industries coincide. She was the first reporter to break news that personalized vitamin company Care/of had been shuttered by its parent company Bayer just four years after the multinational giant purchased the startup for $225 million. Prior to NutraIngredients, Claudia worked for a tech publication covering companies such as Amazon (AWS), Microsoft, Google, Zoom, Cisco and Nvidia. Over the last two decades, she has reported on a variety of topics including artificial intelligence, bioterrorism, climate change, infectious disease spread and the international coffee trade. Claudia’s work has appeared in Newsweek, Science Daily, the Discovery Channel, Deutsche Welle, Current TV, Homeland Preparedness News, the Express Tribune with the International New York Times, and regional Florida newspapers. Her work has been cited in books on sociology, history and the environment. "

All stories

Supplement weight management claims in the GLP-1 era

Supplement weight management claims in the GLP-1 era

By Claudia Adrien

Earlier this year, California resident Christina Robins sued wellness brand Lemme Inc. accusing it of misleading marketing practices surrounding the company’s GLP-1 Daily supplement.

What do US tariffs against India mean for botanical exports?

What do US tariffs against India mean for botanical exports?

By Claudia Adrien

President Trump implemented 50% tariffs on goods from India 10 days ago in retaliation for India’s importation of Russian oil. According to the BBC, prolonged 50% tariffs could ‘shave off’ as much as 0.8% of India’s GDP.